Glaxosmithkline | GSK - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Glaxosmithkline

Glaxosmithkline reported GBP4.87B in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
AbbVie ABBV:US USD 9.46B 162M
Amgen AMGN:US USD 4.07B 538M
AstraZeneca AZN:LN USD 8.33B 1.78B
Bausch Health Companies Inc VRX:CN USD 1.77B 468M
Bristol-Myers Squibb BMY:US USD 8.24B 1.22B
Catalent CTLT:US USD 1.01B 49M
Corcept Therapeutics CORT:US USD 90.8M 10.24M
Drreddys Laboratories RDY:US INR 50.59B 687M
Eli Lilly LLY:US USD 5.47B 600K
Endo International ENDP:US USD 511.81M 280.86M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
Glaxosmithkline GSK:US GBP 4.87B 640M
Horizon Pharma HZNP:US USD 796.06M 27.97M
J&J JNJ:US USD 25.48B 5.98B
Merck & Co MRK:US USD 10.76B 371M
Novartis NOVN:VX USD 10.35B 700M
Pacira PCRX:US USD 180.36M 1.49M
Perrigo PRGO:US USD 1.13B 8.9M
Pfizer PFE:US USD 11.5B 7.63B
Phibro Animal Health PAHC:US USD 227.12M 1.68M
Roche Holding ROG:VX CHF 25.06B 4.31B
Supernus Pharmaceuticals SUPN:US USD 148.59M 15.59M
Takeda 4502:JP JPY 867.59B 81.97B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 3.66B 1.08B
Zoetis ZTS:US USD 1.3B 145M